| Literature DB >> 31138194 |
Ya Guo1, Yang Zhang2, Shu Juan Zhang3, Yi Nan Ma2, Yun He2.
Abstract
BACKGROUND: Radioresistance is one of the main obstacle limiting the therapeutic efficacy and prognosis of patients, the molecular mechanisms of radioresistance is still unclear. The purpose of this study was to identify the key genes and miRNAs and to explore their potential molecular mechanisms in radioresistant nasopharyngeal carcinoma.Entities:
Keywords: Nasopharyngeal carcinoma; microRNA, gene expression omnibus differentially expressed genes, bioinformatics analysis
Mesh:
Substances:
Year: 2019 PMID: 31138194 PMCID: PMC6537399 DOI: 10.1186/s12920-019-0507-6
Source DB: PubMed Journal: BMC Med Genomics ISSN: 1755-8794 Impact factor: 3.063
Differential mRNA expression profile of radioresistant nasopharyngeal carcinoma CNE2R versus CNE-2 cells (The Table 1 show the top 20 differential expression genes)
| Gene Symbol | Description | Fold Change |
|---|---|---|
| LXN | latexin | 22.53 |
| IGFBP3 | insulin-like growth factor binding protein 3 | 18.88 |
| ABCG1 | ATP-binding cassette, sub-family G (WHITE), member 1 | 16.82 |
| CP | ceruloplasmin (ferroxidase) | 14.76 |
| TRIM31 | tripartite motif-containing 31 | 12.30 |
| NNMT | nicotinamide N-methyltransferase | 10.96 |
| GDF15 | growth differentiation factor 15 | 10.15 |
| INHBE | inhibin, beta E | 9.59 |
| EGR1 | early growth response 1 | 7.95 |
| IL8 | interleukin 8 | 7.49 |
| METTL7A | methyltransferase like 7A | 7.31 |
| LOC387763 | hypothetical LOC387763 | 7.24 |
| LCN2 | lipocalin 2 | 6.82 |
| EDN2 | endothelin 2 | 6.57 |
| BMP2 | bone morphogenetic protein 2 | 6.56 |
| C8orf4 | chromosome 8 open reading frame 4 | 6.42 |
| ASNS | asparagine synthetase | 6.12 |
| SLC16A6 | solute carrier family 16, member 6 (monocarboxylic acid transporter 7) | 5.55 |
| PCK2 | phosphoenolpyruvate carboxykinase 2 (mitochondrial) | 5.44 |
| STEAP4 | STEAP family member 4 | 5.32 |
Differentially expressed miRNAs in GSE48502
| miRNA | Fold change | P-value |
|---|---|---|
| Up-regulated miRNA | ||
| hsa-miR-762 | 2.510 | 0.00337 |
| hsa-miR-1202 | 2.292 | 0.0008 |
| hsa-miR-193b | 1.530 | 0.00986 |
| hsa-let-7e | 1.521 | 0.00054 |
| Down-regulated miRNA | ||
| hsa-miR-203 | 3.337 | 0.01698 |
| hsa-miR-545 | 1.980 | 0.04888 |
| hsa-miR-4291 | 1.722 | 0.00271 |
| hsa-miR-183 | 1.677 | 0.03486 |
| hsa-miR-24 | 1.667 | 0.00032 |
| hsa-miR-130a | 1.598 | 0.01252 |
| hsa-miR-660 | 1.578 | 0.01531 |
| hsa-miR-31 | 1.535 | 0.00208 |
| hsa-miR-23a | 1.527 | 0.03552 |
| hsa-miR-30a | 1.526 | 0.0274 |
Fig. 1Screening common genes or miRNAs by Venn diagram software. a Identification common genes between the DEGs and the publicly available studies by Venn diagram. b Analyzed the common microRNAs between the JUN-related microRNAs and DEMs by Venn diagram software
Identification of JUN related microRNA by mirDIP software. Prediction analysis was performed by mirDIP online software. In this table, asterisk represents common microRNA in DEMs and JUN-related microRNAs by Veen analysis
| Gene Symbol | MicroRNA | Integrated Score | Score Class |
|---|---|---|---|
| JUN | hsa-miR-200b-3p | 0.8428 | Excellent |
| JUN | hsa-miR-139-5p | 0.7769 | Excellent |
| JUN | hsa-miR-200c-3p | 0.7693 | Excellent |
| JUN | hsa-miR-429 | 0.7576 | Excellent |
| JUN | hsa-miR-495-3p | 0.7162 | Excellent |
| JUN | hsa-miR-32-5p | 0.6837 | Excellent |
| JUN | hsa-miR-92a-3p | 0.6745 | Excellent |
| JUN | hsa-miR-216b-5p | 0.6528 | Excellent |
| JUN | hsa-miR-522-3p | 0.6392 | Excellent |
| JUN | hsa-miR-501-5p | 0.60082 | Excellent |
| JUN | hsa-miR-200a-3p | 0.5751 | Excellent |
| JUN | hsa-miR-524–5p | 0.5637 | Excellent |
| JUN | hsa-miR-520d-5p | 0.5365 | Excellent |
| JUN | hsa-miR-141–3p | 0.5211 | Excellent |
| JUN | hsa-miR-203* | 0.5019 | Excellent |
| JUN | hsa-miR-580-3p | 0.4817 | Excellent |
| JUN | hsa-miR-940 | 0.4770 | Excellent |
| JUN | hsa-miR-1299 | 0.4628 | Excellent |
| JUN | hsa-miR-9-5p | 0.4390 | Excellent |
| JUN | hsa-miR-612 | 0.4313 | Excellent |
| JUN | hsa-miR-583 | 0.4260 | Excellent |
| JUN | hsa-miR-455-3p | 0.4018 | Excellent |
| JUN | hsa-miR-637 | 0.3870 | Excellent |
| JUN | hsa-miR-92b-3p | 0.3700 | Excellent |
| JUN | hsa-miR-758-3p | 0.3659 | Excellent |
| JUN | hsa-miR-25-3p | 0.3602 | Excellent |
| JUN | hsa-miR-24* | 0.3585 | Excellent |
| JUN | hsa-miR-31* | 0.3585 | Excellent |
| JUN | hsa-miR-493-5p | 0.3318 | Excellent |
| JUN | hsa-miR-127-5p | 0.3255 | Excellent |
| JUN | hsa-miR-633 | 0.3227 | Excellent |
| JUN | hsa-miR-766-3p | 0.3199 | Excellent |
| JUN | hsa-miR-224-3p | 0.3097 | Excellent |
| JUN | hsa-miR-494-3p | 0.3081 | Excellent |
| JUN | hsa-miR-1285-3p | 0.3039 | Excellent |
GO functional annotation of DEMs (Top 10)
| GO Category | Gene Target | miRNAs | P-value |
|---|---|---|---|
| Up-regulated miRNAs | |||
| mitotic cell cycle | 158 | 4 | 0 |
| protein binding transcription factor activity | 143 | 4 | 0 |
| RNA binding | 473 | 4 | 0 |
| nucleoplasm | 369 | 4 | 0 |
| cytosol | 664 | 4 | 0 |
| biosynthetic process | 909 | 4 | 0 |
| gene expression | 234 | 4 | 0 |
| viral process | 177 | 4 | 0 |
| cellular nitrogen compound metabolic process | 1112 | 4 | 0 |
| ion binding | 1145 | 4 | 0 |
| Down-regulated miRNAs | |||
| nucleoplasm | 612 | 18 | 0 |
| biosynthetic process | 1636 | 18 | 0 |
| gene expression | 389 | 18 | 0 |
| cellular nitrogen compound metabolic process | 2032 | 18 | 0 |
| organelle | 3947 | 18 | 0 |
| ion binding | 2198 | 16 | 0 |
| mitotic cell cycle | 221 | 15 | 0 |
| RNA binding | 812 | 15 | 0 |
| cellular protein modification process | 985 | 15 | 0 |
| cytosol | 1170 | 15 | 0 |
Fig. 2GO functional annotation of DEGs. a The top 20 significant biology process of up-regulated genes. b The significant biology process of down-regulated genes
Fig. 3Pathway enrichment analysis of DEMs target genes and DEGs. a The top 30 enriched kegg pathway for DEMs target genes. b Significant pathways in up-regulated genes. c Venn diagrams show the common pathway between upregulated genes and DEMs target genes. d Biomolecular network about 5 validated genes (in red) targeted by the common microRNAs and corresponding pathways were analyzed by Clue Go and Clue Pedia. The yellow diamond nodes represent target gene, the violet circle and red circle nodes represent miRNA and their related pathway respectively
Fig. 4Constructed PPI network of DEGs by STRING software. Using the STRING software, proteins are represented with nodes and the interactions with continuous lines to represent direct interactions (physical), while indirect ones (functional) are presented by interrupted lines. Line thickness indicates the strength of data support
Fig. 5Significant subnetwork of DEGs. Red nodes represent up-regulated genes, while Green nodes denote down-regulated genes. The size of the nodes is positively correlated with the count of genes. The color of line is determined by the combined score provided by STRING